PRKAA1 and metabolic dysfunction-associated steatotic liver disease: Of these pathways in Figure 5B, AMPK piqued our interest as AMPK is a main and well‐known regulating protein for lipid metabolism, and AMPK activation has been proposed to be therapeutically beneficial for NAFLD.27